---
title: "Bharat Parenterals Ltd (541096) — Share Price, Financials & Analysis"
symbol: "541096"
company: "Bharat Parenterals Ltd"
canonical: "https://tapetide.com/stocks/541096"
isin: "INE365Y01019"
nse_symbol: "BPLPHARMA"
bse_code: "541096"
sector: "Healthcare"
industry: "Pharmaceuticals"
market_cap_cr: 1033.79
generated_at: "2026-09-13T18:26:53.731Z"
---

# Bharat Parenterals Ltd (541096)

Canonical page: https://tapetide.com/stocks/541096

## Company

- **NSE Symbol:** BPLPHARMA
- **BSE Code:** 541096
- **ISIN:** INE365Y01019
- **Sector:** Healthcare
- **Industry:** Pharmaceuticals
- **Macro Sector:** Healthcare
- **Stock Type:** EQUITY
- **Listed Since:** 2018-03-21
- **CEO:** Mr. Bharatkumar Rameshchandra Desai
- **Employees:** 393
- **Face Value:** ₹10
- **F&O Eligible:** No
- **Website:** bplindia.in

## About

Incorporated in 1992, Bharat Parenterals Ltd is in the business of manufacturing and marketing of formulations[1]

## Latest Price

- **Price:** ₹1505.1
- **Change:** -52.5 (-3.37%)
- **Open:** ₹1558.6
- **Day High:** ₹1577
- **Day Low:** ₹1449.8
- **Previous Close:** ₹1557.6
- **Volume:** 8418
- **As Of:** 2026-09-11T09:59:51+00:00

## Key Fundamentals

Observed at 2026-09-11T04:52:30.626627Z.

- **Market Cap:** ₹1033.79 Cr
- **Classification:** Microcap
- **P/E (reported):** -35.6
- **EPS (TTM):** ₹-22.35
- **Book Value:** ₹467.55
- **Price to Book:** 3.32
- **Dividend Yield:** 0.06%
- **ROE:** -8.76%
- **ROCE:** -1.95%
- **Debt to Equity:** 0.45
- **Revenue (yearly):** ₹355 Cr
- **Net Income:** ₹-27.3 Cr
- **EBITDA:** ₹25.4 Cr
- **52-Week High:** ₹1649
- **52-Week Low:** ₹1125.7
- **RSI (14):** 90.57

## Tapetide Score

- **Score:** 44 / 100
- **Score date:** 2026-09-04
- **Archetype:** Trend Ahead of Fundamentals
- **What it means:** The price trend is running ahead of what the financials currently support. Moves like this depend on the fundamentals catching up; check what would have to be true for that.
- **Pillar profile:** Quality: Weak · Valuation: Expensive · Momentum: Rising
- **Percentile:** 25 (of 4473 scored stocks)
- **Confidence:** 93%
- **Data coverage:** 86%

| Pillar | Score | Weight |
| --- | --- | --- |
| financial health | 26.23 | 9% |
| growth | 2.76 | 9% |
| momentum | 72.78 | 12% |
| ownership | 62.54 | 24% |
| quality | 44.16 | 22% |
| valuation | 36.64 | 24% |

The Tapetide Score is decision-support only, not investment advice.

## Key Insights

### Weaknesses

- Stock is trading at 3.22 times its book value
- Company has low interest coverage ratio.
- Company has a low return on equity of -0.79% over last 3 years.
- Company might be capitalizing the interest cost
- Earnings include an other income of Rs.9.60 Cr.
- Company has high debtors of 159 days.
- Promoter holding has decreased over last 3 years: -6.64%
- Working capital days have increased from 100 days to 143 days

## Growth Rates

| Metric | QoQ | 1Y | 3Y | 5Y |
| --- | --- | --- | --- | --- |
| cash flow growth | — | 240.77% | 914.44% | — |
| ebitda margin growth | 212.9% | 75.43% | -40.2% | -55.71% |
| net income growth | 56.1% | -37.53% | -360% | -231.25% |
| revenue growth | -8.23% | 0.85% | 17% | 11% |
| roce | -117.39% | -60.37% | -126.93% | 5.42% |
| roe | -56.37% | -31.99% | -5.74% | -171.63% |

## Financial Statements

### Quarterly Results

All figures in ₹ crore unless the row name says otherwise.

| Item | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 59.81 | 59.82 | 67.82 | 92.51 | 71.63 | 72.26 | 103.98 | 116 | 64.62 | 65.19 | 99.62 | 93.74 |
| Expenses | 55.49 | 53.21 | 66.82 | 88.02 | 79.29 | 68.62 | 101.75 | 102.22 | 63.79 | 63.45 | 100.14 | 85.21 |
| Operating Profit | 4.32 | 6.61 | 1 | 4.49 | -7.66 | 3.64 | 2.23 | 13.78 | 0.83 | 1.74 | -0.52 | 8.53 |
| OPM % | 7.22 | 11.05 | 1.47 | 4.85 | -10.69 | 5.04 | 2.14 | 11.88 | 1.28 | 2.67 | -0.52 | 9.1 |
| Other Income | 2.6 | 1.26 | 2.64 | 2.54 | 4.21 | 2.94 | 1.93 | 1.06 | 3.53 | 1.33 | 3.63 | 1.11 |
| Interest | 0.63 | 0.58 | 1.13 | 2.77 | 2.91 | 3.33 | 3.94 | 3.69 | 3.11 | 2.9 | 2.85 | 2.45 |
| Depreciation | 1.75 | 1.82 | 3.87 | 9.03 | 9.01 | 8.76 | 8.52 | 8.6 | 8.56 | 8.46 | 8.63 | 8.69 |
| Profit before tax | 4.54 | 5.47 | -1.36 | -4.77 | -15.37 | -5.51 | -8.3 | 2.55 | -7.31 | -8.29 | -8.37 | -1.5 |
| Tax % | 46.48 | 33.46 | 88.24 | 85.32 | 13.92 | 43.01 | 13.61 | 133.73 | 17.65 | 16.77 | -2.51 | 138 |
| Net Profit | 2.43 | 3.64 | -2.56 | -8.84 | -17.51 | -7.88 | -9.44 | -0.87 | -8.6 | -9.67 | -8.16 | -3.56 |
| EPS in Rs | 6.05 | 6.5 | -0.52 | 1.96 | -11.5 | -2.42 | -6.86 | 11.94 | -10.49 | -6.37 | -6.96 | 1.47 |

### Profit & Loss

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 | TTM |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Sales | 137 | 220 | 228 | 205 | 212 | 218 | 261 | 340 | 345 | 323 |
| Expenses | 124 | 191 | 200 | 179 | 183 | 198 | 234 | 337 | 330 | 313 |
| Operating Profit | 12 | 29 | 28 | 25 | 29 | 20 | 27 | 4 | 16 | 11 |
| OPM % | 9 | 13 | 12 | 12 | 14 | 9 | 10 | 1.1 | 4.6 | 3.3 |
| Other Income | 7 | 13 | 11 | 9 | 7 | 12 | 5 | 11 | 10 | 10 |
| Interest | 1 | 1 | 1 | 1 | 1 | 3 | 4 | 13 | 13 | 11 |
| Depreciation | 6 | 6 | 6 | 6 | 7 | 6 | 9 | 35 | 34 | 34 |
| Profit before tax | 13 | 35 | 33 | 27 | 28 | 24 | 19 | -34 | -21 | -25 |
| Tax % | 29 | 39 | 26 | 25 | 25 | 33 | 44 | 29 | 27 | — |
| Net Profit | 9 | 21 | 24 | 20 | 21 | 16 | 11 | -44 | -27 | -30 |
| EPS in Rs | 15.92 | 37.09 | 42.13 | 35.59 | 36.45 | 28.47 | 24.95 | -18.33 | -11.88 | -22.35 |
| Dividend Payout % | 0 | 0 | 0 | 0 | 0 | 3 | 4 | -5 | -8 | — |

### Balance Sheet

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Equity Capital | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 6 | 7 | 7 |
| Reserves | 58 | 67 | 88 | 112 | 138 | 160 | 177 | 191 | 324 | 315 |
| Borrowings | 6 | 9 | 5 | 1 | 12 | 18 | 50 | 158 | 180 | 146 |
| Other Liabilities | 40 | 50 | 60 | 68 | 43 | 42 | 118 | 149 | 138 | 145 |
| Total Liabilities | 110 | 132 | 159 | 188 | 199 | 226 | 350 | 504 | 649 | 613 |
| Fixed Assets | 31 | 34 | 35 | 33 | 45 | 41 | 42 | 211 | 252 | 255 |
| CWIP | 0 | 0 | 1 | 12 | 0 | 26 | 99 | 25 | 31 | 35 |
| Investments | 1 | 1 | 1 | 0 | 43 | 11 | 0 | 0 | 5 | 6 |
| Other Assets | 79 | 98 | 121 | 142 | 111 | 148 | 209 | 268 | 360 | 317 |
| Total Assets | 110 | 132 | 159 | 188 | 199 | 226 | 350 | 504 | 649 | 613 |

### Cash Flow

All figures in ₹ crore unless the row name says otherwise.

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Cash from Operating Activity | -2 | 6 | 20 | 14 | 24 | -1 | 22 | -5 | -27 | 38 |
| Cash from Investing Activity | -2 | -8 | -9 | -13 | -43 | -7 | -78 | -105 | -137 | 9 |
| Cash from Financing Activity | -8 | 4 | -4 | -3 | 10 | 9 | 61 | 110 | 156 | -47 |
| Net Cash Flow | -11 | 2 | 7 | -1 | -8 | 2 | 4 | 1 | -8 | 1 |
| Free Cash Flow | -4 | -2 | 12 | 0 | 24 | -40 | -68 | -108 | -56 | -1 |
| CFO/OP | -8 | 73 | 107 | 87 | 123 | 16 | 150 | 18 | -444 | 305 |

### Ratios

| Item | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Debtor Days | 143 | 157 | 106 | 127 | 121 | 126 | 188 | 198 | 184 | 159 |
| Inventory Days | 70 | 60 | 59 | 71 | 61 | 56 | 100 | 142 | 132 | 162 |
| Days Payable | 168 | 110 | 83 | 104 | 71 | 64 | 136 | 137 | 136 | 122 |
| Cash Conversion Cycle | 45 | 107 | 82 | 93 | 111 | 118 | 152 | 202 | 180 | 199 |
| Working Capital Days | 64 | 78 | 73 | 89 | 106 | 148 | 91 | 81 | 76 | 143 |
| ROCE % | 11 | 18 | 39 | 31 | 20 | 17 | 11 | 7 | -4 | -2 |

## Shareholding Pattern

### Quarterly

| Category | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 | Dec 2025 | Mar 2026 | Jun 2026 |
| --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- | --- |
| Promoters | 73.84% | 73.84% | 73.26% | 73.27% | 65.35% | 67.2% | 67.2% | 67.19% | 67.19% | 67.19% | 67.17% | 67.2% |
| FIIs | 0% | 0% | 0% | 0% | 0.08% | 0.11% | 0.11% | 0.11% | 0.11% | 0.11% | 0.11% | 0.11% |
| DIIs | 0.01% | 0.01% | 0.01% | 0.01% | 0.57% | 0.54% | 0.54% | 0.54% | 0.54% | 0.54% | 1.06% | 1.37% |
| Government | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
| Public | 13% | 12.99% | 13.61% | 13.6% | 20.07% | 19.2% | 18.94% | 19.31% | 19.27% | 19.21% | 18.86% | 18.54% |
| Others | 13.15% | 13.16% | 13.11% | 13.13% | 13.92% | 12.95% | 13.21% | 12.85% | 12.89% | 12.94% | 12.8% | 12.78% |
| No. of Shareholders | 2481 | 2397 | 2497 | 2727 | 2748 | 3116 | 3177 | 3231 | 3205 | 3172 | 3095 | 3059 |

## Technical Indicators

Derived from daily closing prices and recomputed each trading session; values move with the market.

- **Overall Signal:** Strong Buy
- **Buy / Neutral / Sell:** 10 / 6 / 3

### Moving Averages — summary: **Strong Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| SMA (10) | 1530.93 | Sell |
| EMA (10) | 1520.73 | Sell |
| SMA (20) | 1466.32 | Buy |
| EMA (20) | 1491.74 | Buy |
| SMA (50) | 1440.22 | Buy |
| EMA (50) | 1439.25 | Buy |
| SMA (100) | 1370.83 | Buy |
| EMA (100) | 1374 | Buy |
| SMA (200) | 1238.23 | Buy |
| EMA (200) | 1300.3 | Buy |

### Oscillators — summary: **Buy**

| Indicator | Value | Signal |
| --- | --- | --- |
| RSI (14) | 53.63 | Neutral |
| MACD (12,26,9) | 35.85 | Buy |
| Stochastic (14,3,3) | 53.54 | Neutral |
| ADX (14) | 21.66 | Neutral |
| Williams %R (14) | -60.41 | Neutral |
| ATR (14) | 93.2 | High Volatility |
| ROC (12) | -2.34 | Sell |
| Stoch RSI (14) | 0 | Buy |
| UO (7,14,28) | 42.02 | Neutral |

## Filings & Documents

### Exchange Filings & Announcements

| Date | Document |
| --- | --- |
| 2026-08-28 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=faace39a-d781-4533-9e60-658c6f10bf6c.pdf) |
| 2026-08-27 | [Notice Of 33Rd Annual General Meeting Of The Comapny Schedule On September 19 2026.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ffe9bc03-484a-4431-b3df-956af1b69c1d.pdf) |
| 2026-08-27 | [Reg. 34 (1) Annual Report.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=42a1ef90-b59b-4ee6-9b1f-d48a4adabb19.pdf) |
| 2026-08-27 | [Intimation Of The Record Date For The Purpose Of The Dividend For FY 2025-26.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=27fa1cc2-ed3a-431d-9819-e7f558552288.pdf) |
| 2026-08-27 | [Intimation Under Regulation 36 Of The SEBI (LODR) Regulations 2015.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=24a2f38d-e4a8-445f-b913-64f9ae47b70a.pdf) |
| 2026-08-24 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=f9dbfe8d-36f2-458e-94e8-12cc08af1e4e.pdf) |
| 2026-08-20 | [Intimation Regarding Permission To Trade And Admission Of Equity Shares To Dealings On The National Stock Exchange Of India Limited.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=80b08b31-690a-46da-bbe8-52ced92eecb2.pdf) |
| 2026-08-14 | [Announcement under Regulation 30 (LODR)-Newspaper Publication](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=fb1a39eb-ff6c-4a92-9bc4-475257db4701.pdf) |
| 2026-08-11 | [Announcement under Regulation 30 (LODR)-Press Release / Media Release](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cf7aa011-5ffa-416a-a6ce-1ed61fcb985e.pdf) |
| 2026-08-10 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=e9235f75-5824-44f8-a54f-577bc3cc0e31.pdf) |

### Results & Financial Statements

| Date | Document |
| --- | --- |
| 2026-08-05 | [Financial Results For The Quarter Ended On June 30 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=34093883-bfe9-48a1-933f-c73ec64ec358.pdf) |
| 2026-05-18 | [Audited Financial Results For The Quarter And Year Ended March 31 2026](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=8165952b-6b2c-4404-873b-58b15ea75f0a.pdf) |
| 2026-01-30 | [Financial Results For The Quarter And Nine Months Ended On December 31 2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=03749192-6f8a-4259-a0c5-48a603871c3b.pdf) |
| 2025-11-12 | [For The Quarter And Half Year Ended September 30 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=aa3b0581-df8e-42e6-a309-1b4ff3fc9c8b.pdf) |
| 2025-07-28 | [Financial Results For The Quarter Ended On June 30 2025](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=cbabcf81-73f2-409a-baad-e6d6aed39839.pdf) |
| 2025-05-12 | [Board Meeting Outcome for Outcome Of Board Meeting](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=33a11ded-5a04-4262-bebb-dd949d3816d6.pdf) |
| 2025-05-12 | [Audited Financial Results For The Quarter And Year Ended March 31 2025.](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=27b08023-7483-4571-9e7e-b2473d6c1193.pdf) |
| 2025-02-03 | [Unaudited Standalone And Consolidated Financial Results For The Quarter And Nine Months Ended On 31St December2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=49243adc-7f0d-418f-a6d0-827cee8a09ff.pdf) |
| 2024-10-29 | [Financial Results For Half Year Ended On 30Th September, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=913966fc-7f49-4b70-94f5-f43c1401d624.pdf) |
| 2024-08-08 | [Standalone & Consolidated Financial Result For Quarter Ended On 30Th June, 2024](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=bca17b31-7d46-4365-9244-6372258a4443.pdf) |

### Investor Presentations

| Date | Document |
| --- | --- |
| 2026-08-05 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=11c2bb4a-2bd7-42da-aace-73c8cca0da29.pdf) |
| 2026-05-18 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=1c0c5241-72f4-45f1-b686-e114a79efcbe.pdf) |
| 2026-01-30 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=2782e10a-728e-4e42-b632-7bfe0c9367af.pdf) |
| 2025-11-12 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=4e21ebfb-e9a2-4d2e-9d77-f45fcf0e10c8.pdf) |
| 2025-07-28 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=b8cb92bd-2b78-48aa-af2e-a97d23d4b1df.pdf) |
| 2024-05-23 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a7195d70-b77c-42de-86c5-5f6ad4415592.pdf) |
| 2024-02-20 | [Announcement under Regulation 30 (LODR)-Investor Presentation](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=da6aebcb-7527-43a1-9fcf-081542c30697.pdf) |

### Earnings Call Transcripts

| Date | Document |
| --- | --- |
| 2026-05-20 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=d7bf5110-79a8-434d-a578-3ecec92f64ca.pdf) |
| 2025-11-17 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=a0b0ad58-8ba7-4730-8b3f-5d7a4b785692.pdf) |
| 2025-05-19 | [Announcement under Regulation 30 (LODR)-Earnings Call Transcript](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=0b9d12a0-d184-4d4f-b04b-df471a5a9a41.pdf) |

### Earnings Call Recordings

| Date | Document |
| --- | --- |
| 2026-05-19 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=9a817ad3-6541-4ab6-810f-aa1e2e28382c.pdf) |
| 2025-11-12 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=af998373-4dbd-4488-92a2-b82dee22ed2b.pdf) |
| 2025-05-14 | [Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome](https://www.bseindia.com/stockinfo/AnnPdfOpen.aspx?Pname=ef725e53-a151-435e-9ad7-3a90af4172a1.pdf) |

### Other Documents

| Date | Document |
| --- | --- |
| 8 Apr - Submitted Regulation 74(5) confirmation certificate for quarter ended March 31, 2026. | [Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018 8 Apr - Submitted Regulation 74(5) confirmation certificate for quarter ended March 31, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0498d64f-6add-4971-beb4-b060b4cfb6af.pdf) |
| 8 Apr - Newspaper notice to physical shareholders informing them about the special window for re-lodge the share transfer deed. | [Announcement under Regulation 30 (LODR)-Newspaper Publication 8 Apr - Newspaper notice to physical shareholders informing them about the special window for re-lodge the share transfer deed.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a5dfe032-f5a5-439b-becc-72c46a4e5e00.pdf) |
| 6 Feb - Board meeting 12 Feb 2026 to approve unaudited Q3 results for quarter ended 31 Dec 2025. | [Board Meeting Intimation for BOARD MEETING TO BE HELD ON 12TH FEBRUARY, 2026 6 Feb - Board meeting 12 Feb 2026 to approve unaudited Q3 results for quarter ended 31 Dec 2025.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0c4c9cf6-7847-4fa9-b3b8-3496c40890a0.pdf) |
| 31 Jan - Copy of newspaper advertisement for the unaudited financial results for the quarter and nine months ended December 31, 2025. | [Announcement under Regulation 30 (LODR)-Newspaper Publication 31 Jan - Copy of newspaper advertisement for the unaudited financial results for the quarter and nine months ended December 31, 2025.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/8ec77272-773e-4442-957e-b8859ae8a4be.pdf) |
| 30 Jan - Q3 FY26: standalone revenue ₹41.41cr, consolidated loss ₹9.63cr; order book ₹303cr; EU GMP audit zero observations. | [Board Meeting Outcome for Outcome Of Board Meeting For The Unaudited Standalone And Consolidated Financial Results For The Quarter And Nine Months Ended On December 31, 2025. 30 Jan - Q3 FY26: standalone revenue ₹41.41cr, consolidated loss ₹9.63cr; order book ₹303cr; EU GMP audit zero observations.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/62477bb3-7ab6-4a4c-a0a1-60a90f40c224.pdf) |
| 30 Jan - Investor Presentation for the Quarter and Nine Months Ended on December 31, 2025. | [Announcement under Regulation 30 (LODR)-Investor Presentation 30 Jan - Investor Presentation for the Quarter and Nine Months Ended on December 31, 2025.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/2782e10a-728e-4e42-b632-7bfe0c9367af.pdf) |
| 2d - Board meeting on May 18, 2026 to approve FY26 audited results, statements, and consider final dividend. | [Board Meeting Intimation for Approving Audited Financial Results For The Quarter And Year Ended March 31, 2026 And Recommendation Of Final Dividend On Equity Shares. 2d - Board meeting on May 18, 2026 to approve FY26 audited results, statements, and consider final dividend.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/331cecd9-b5ec-4944-8e79-188410ad9727.pdf) |
| 29 Apr - Newspaper Advertisement Under Regulation 30 of SEBI LODR (LODR), Regulations 2015. | [Announcement under Regulation 30 (LODR)-Newspaper Publication 29 Apr - Newspaper Advertisement Under Regulation 30 of SEBI LODR (LODR), Regulations 2015.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/1cb12dc0-81a0-4f3e-a307-bc5c224fc0ed.pdf) |
| 29 Apr - Newspaper Advertisement Under Regulation 30 of SEBI LODR (LODR), Regulations 2015. | [Announcement under Regulation 30 (LODR)-Newspaper Publication 29 Apr - Newspaper Advertisement Under Regulation 30 of SEBI LODR (LODR), Regulations 2015.](https://www.bseindia.com/xml-data/corpfiling/AttachLive/1cb12dc0-81a0-4f3e-a307-bc5c224fc0ed.pdf) |
| 29 Apr - Bharat Parenterals confirms it is not a Large Corporate; outstanding borrowing was Rs 15.77 crore as of March 31, 2026. | [Format of the Initial Disclosure to be made by an entity identified as a Large Corporate : Annexure A 29 Apr - Bharat Parenterals confirms it is not a Large Corporate; outstanding borrowing was Rs 15.77 crore as of March 31, 2026.](https://www.bseindia.com/xml-data/corpfiling/AttachHis/ad891646-6efe-4c25-a947-41541ce428d1.pdf) |

### Earnings Call Documents

| Date | Document |
| --- | --- |
| Nov 2025 | [Concall - Nov 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a0b0ad58-8ba7-4730-8b3f-5d7a4b785692.pdf) |
| Nov 2021 | [Concall - Nov 2021](https://www.bseindia.com/xml-data/corpfiling/AttachHis/c3482584-7fea-4ad1-8d75-6ca6226787bc.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachHis/d7bf5110-79a8-434d-a578-3ecec92f64ca.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachLive/d7bf5110-79a8-434d-a578-3ecec92f64ca.pdf) |
| May 2026 | [Concall - May 2026](https://www.bseindia.com/xml-data/corpfiling/AttachLive/1c0c5241-72f4-45f1-b686-e114a79efcbe.pdf) |
| May 2025 | [Concall - May 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/0b9d12a0-d184-4d4f-b04b-df471a5a9a41.pdf) |
| May 2024 | [Concall - May 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a7195d70-b77c-42de-86c5-5f6ad4415592.pdf) |
| May 2021 | [Concall - May 2021](https://www.bseindia.com/xml-data/corpfiling/AttachHis/a663bfd6-8fb3-480a-b17e-078fd7017536.pdf) |
| Jul 2025 | [Concall - Jul 2025](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b8cb92bd-2b78-48aa-af2e-a97d23d4b1df.pdf) |
| Feb 2024 | [Concall - Feb 2024](https://www.bseindia.com/xml-data/corpfiling/AttachHis/da6aebcb-7527-43a1-9fcf-081542c30697.pdf) |

### Annual Reports

| Date | Document |
| --- | --- |
| from bse | [Annual Report 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/dc9d92c0-b5ac-446b-8588-82768e910355.pdf) |
| from bse | [Financial Year 2025 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/86c4cf17-da2d-416e-a7d6-c100c59cef6f.pdf) |
| from bse | [Annual Report 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/634aed23-f41d-483d-ad1f-6cebce39b16a.pdf) |
| from bse | [Financial Year 2024 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/fb16beae-ae79-4c14-969d-3af86d045b8f.pdf) |
| from bse | [Annual Report 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/b37b75e3-b862-4373-b808-b5a79d6f9407.pdf) |
| from bse | [Financial Year 2023 from bse](https://www.bseindia.com/xml-data/corpfiling/AttachHis/87de054e-c952-40fd-a30b-aef15f94e79f.pdf) |
| from bse | [Annual Report 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/541096/75326541096.pdf) |
| from bse | [Financial Year 2022 from bse](https://www.bseindia.com/bseplus/AnnualReport/514300/73247514300.pdf) |
| from bse | [Annual Report 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/541096/71384541096.pdf) |
| from bse | [Financial Year 2021 from bse](https://www.bseindia.com/bseplus/AnnualReport/514300/68637514300.pdf) |

---

Provenance differs by section. Financial statements, shareholding and filings are as reported in company disclosures to NSE/BSE/SEBI. Price, volume and 52-week levels are exchange market data. Technical indicators are computed by Tapetide from daily closing prices. The Tapetide Score is Tapetide's own analysis. Analyst ratings are third-party estimates, not company statements. All figures are for research and information only and are not investment advice. Generated 2026-09-13T18:26:53.731Z.